Eugene Boland, Ph.D., has over 20 years in laboratory research, with a specific focus on developing engineering solutions for cardiovascular diseases as well as chronic wounds. His materials expertise extends from bioinert metals and ceramics to bioactive and bioresorbable electrospun polymers and proteins. After receiving his Bachelors of Science in Biomedical Engineering from Marquette University in 1994, Dr. Boland went on to receive his Ph.D. in Biomedical Engineering from Virginia Commonwealth University in 2004 after 6 years in cardiovascular medical device field.
Dr. Boland has held senior engineering positions with companies such as St. Jude Medical Inc., Cordis (a Johnson & Johnson Co.) and Cryolife before completing his doctorate. More recently he has held the position of principal scientist with Tissue Genesis, Inc., and Chief of Regenerative Medicine at the University of Louisville’s Cardiovascular Innovation Institute before accepting his current position as Chief Scientist at Techshot.
Combining his past expertise in materials with his current research utilizing adipose-derived microvascular and adult stem cells (ADSCs), Dr. Boland has developed an epicardial heart patch for “micro-CAVG”, as well as initiated clinical trials to advance the therapeutic use of ADSCs for peripheral and coronary vascular diseases. He has also co-developed ADSC specific digestion solutions for clinical and research applications, as well as developed applications and delivery systems for ADSCs in regenerative medicine and wound healing.
He is currently leading a collaborative team to develop a microgravity bioprinter for installation aboard the International Space Station both for materials research and as a commercial organ development platform.